Citigroup’s LianBio American Depositary Shares LIAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-615,940
Closed -$918K 5903
2023
Q3
$918K Sell
615,940
-91,396
-13% -$174K ﹤0.01% 2591
2023
Q2
$1.61M Sell
707,336
-16,300
-2% -$37.5K ﹤0.01% 2420
2023
Q1
$1.41M Buy
723,636
+16,300
+2% +$33.8K ﹤0.01% 2284
2022
Q4
$1.16M Hold
707,336
﹤0.01% 2481
2022
Q3
$1.41M Buy
707,336
+258,817
+58% +$619K ﹤0.01% 2441
2022
Q2
$969K Sell
448,519
-85,276
-16% -$290K ﹤0.01% 2682
2022
Q1
$1.98M Buy
+533,795
New +$2.2M ﹤0.01% 2367

Other funds holding LIAN

Citigroup's LIAN Position: Q4 2023 in Review

Citigroup sold out of LianBio American Depositary Shares (LIAN) in Q4 2023, closing a stake of 615,940 shares — an estimated $918K sold.

Citigroup first reported a position in LIAN in Q1 2022 and held it in 7 quarters. The position peaked at $1.98M in Q1 2022. 29 funds tracked by Wall St. Rank hold LIAN as of Q4 2023.

  • Citigroup reported no remaining LianBio American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Citigroup sold 615,940 LianBio American Depositary Shares shares in Q4 2023, an estimated $918K.
  • Citigroup first reported a position in LianBio American Depositary Shares in Q1 2022 and held it in 7 quarters.
  • Citigroup's LianBio American Depositary Shares position peaked at $1.98M in Q1 2022.
  • 29 funds tracked by Wall St. Rank held LianBio American Depositary Shares as of Q4 2023.

Based on Citigroup's 13F filing for Q4 2023, filed 9 Feb 2024.